CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)	Common Stock	Additional Paid-in Capital 10% Warrants	Additional Paid-in Capital 15% Warrants	Additional Paid-in Capital	Accumulated Deficit	10% Warrants	15% Warrants	Total
Balance at the beginning of the year at Dec. 31, 2019	$ 39,498			$ 61,468,034	$ (67,271,744)			$ (5,764,212)
Balance at the beginning of the year (in Shares) at Dec. 31, 2019	39,497,480
Warrants exercised	$ 200			172,041				172,241
Warrants exercised (in shares)	200,000
Common stock issued upon conversion of debt	$ 2,215			954,841				957,056
Common stock issued upon conversion of debt (in shares)	2,215,892
Beneficial conversion feature				233,500				233,500
Cashless exercise of warrants	$ 374			821,164				821,538
Cashless exercise of warrants (in shares)	373,340
Sale of common stock, net of issuance costs	$ 43			99,957				100,000
Sale of common stock, net of issuance costs (in shares)	42,735
Common stock issued for acquisition of SevenFive Farms	$ 8,859			1,894,522				1,903,381
Common stock issued for acquisition of SevenFive Farms (in shares)	8,859,117
Warrants issued with Notes			$ 835,499				$ 835,499
Stock-based compensation				926,698				926,698
Net loss					(3,955,086)			(3,955,086)
Balance at the end of the year at Jun. 30, 2020	$ 51,189			67,406,256	(71,226,830)			(3,769,385)
Balance at the end of the year(in Shares) at Jun. 30, 2020	51,188,564
Balance at the beginning of the year at Mar. 31, 2020	$ 40,282			63,550,821	(69,285,923)			(5,694,820)
Balance at the beginning of the year (in Shares) at Mar. 31, 2020	40,281,881
Common stock issued upon conversion of debt	$ 1,674			705,382				707,056
Common stock issued upon conversion of debt (in shares)	1,674,226
Cashless exercise of warrants	$ 374			821,164				821,538
Cashless exercise of warrants (in shares)	373,340
Common stock issued for acquisition of SevenFive Farms	$ 8,859			1,894,522				1,903,381
Common stock issued for acquisition of SevenFive Farms (in shares)	8,859,117
Stock-based compensation				434,367				434,367
Net loss					(1,940,907)			(1,940,907)
Balance at the end of the year at Jun. 30, 2020	$ 51,189			67,406,256	(71,226,830)			(3,769,385)
Balance at the end of the year(in Shares) at Jun. 30, 2020	51,188,564
Balance at the beginning of the year at Dec. 31, 2020	$ 60,813			75,891,414	(74,951,436)			1,000,791
Balance at the beginning of the year (in Shares) at Dec. 31, 2020	60,813,673
Common stock issued to a consultant	$ 112			99,888				100,000
Common stock issued to a consultant (in Shares)	112,359
Common stock issued upon exercise of stock options	$ 334			181,375				$ 181,709
Common stock issued upon exercise of stock options (in shares)	333,620							333,620
Warrants issued with Notes		$ 1,239,300				$ 1,239,300
Beneficial conversion feature				1,110,039				$ 1,110,039
Cashless exercise of warrants	$ 1,005			1,556,073				1,557,078
Cashless exercise of warrants (in shares)	1,006,623
Stock-based compensation				62,284				62,284
Net loss					(3,735,321)			(3,735,321)
Balance at the end of the year at Jun. 30, 2021	$ 62,264			80,140,373	(78,686,757)			1,515,880
Balance at the end of the year(in Shares) at Jun. 30, 2021	62,266,275
Balance at the beginning of the year at Mar. 31, 2021	$ 62,144			78,632,934	(77,310,504)			1,384,574
Balance at the beginning of the year (in Shares) at Mar. 31, 2021	62,146,515
Common stock issued upon exercise of stock options	$ 120			46,587				46,707
Common stock issued upon exercise of stock options (in shares)	119,760
Beneficial conversion feature				692,500				692,500
Warrants issued with Notes		$ 810,000				$ 810,000
Stock-based compensation				(41,648)				(41,648)
Net loss					(1,376,253)			(1,376,253)
Balance at the end of the year at Jun. 30, 2021	$ 62,264			$ 80,140,373	$ (78,686,757)			$ 1,515,880
Balance at the end of the year(in Shares) at Jun. 30, 2021	62,266,275